The second group features R-spondin 3 (Rspo3), collagen and calcium binding EGF domains 1 (Ccbe1), and Shisa homolog 3 (Shisa3) genes, potentially relevant to colorectal cancer and therapy. This evidence concerns the gene SHISA3 and colorectal cancer.